Biotech

All Articles

Analysts examine Avidity's DMD gain, revealing distinctions in records

.Avidity Biosciences amazed capitalists along with stage 1/2 records in Duchenne muscle dystrophy (D...

Actinogen's cortisol blocker falls short stage 2 anxiety research

.Actinogen Medical's cortisol blocker has actually overlooked the primary endpoint of a phase 2 rese...

Bivictrix decides going exclusive only method to take ADC into clinic

.Antibody-drug conjugates (ADCs) have actually gone to the facility of a lot of a billion-dollar bio...

TPG leadings up funds to $580M for financial investments all over life scientific researches

.Property manager TPG, which has actually sustained biotechs including Sionna Rehabs and also Santa ...

Merck quits period 3 TIGIT trial in lung cancer for impossibility

.Merck &amp Co.'s TIGIT course has actually gone through another misfortune. Months after shuttering...

After a challenging year, Exscientia folds up in to Recursion

.After a year determined through pipeline hairstyles, the variation of its own CEO and layoffs, Exsc...

Cullinan, after $25M deal, hands back bispecific to Harbour

.Cullinan Rehab was excited enough along with Harbour BioMed's bispecific immune system reactor that...

A more detailed take a look at Fierce Biotech's Brutal 15

.In this week's incident of "The Best Line," our team're diving in to Fierce Biotech's annual Fierce...

Lilly encounters phase 2 breakdown of tau-targeting med

.The confetti is still flying from Eli Lilly's celebration commemorating the approval of Alzheimer's...

Biogen CMO Maha Radhakrishnan participates in Sofinnova-- Chutes &amp Ladders

.Invite to this week's Chutes &amp Ladders, our summary of considerable management hirings, shooting...